(Reuters) - A U.S. appeals court on Monday postponed an injunction that would have stopped Medtronic Inc from selling its CoreValve heart valve implant in competition with Edwards Lifesciences Corp's Sapien valve product. The injunction, issued by a U.S. District Court in Delaware last week, would have taken effect on April 23. Earlier court decisions found Medtronic's product infringed on the Edwards valve. Monday's ruling means the injunction would take effect only if the appellate court determined it was properly issued, Medtronic said. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment